X-71147819-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate
The NM_181303.2(NLGN3):c.70C>T(p.Leu24Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000179 in 111,987 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_181303.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NLGN3 | NM_181303.2 | c.70C>T | p.Leu24Phe | missense_variant | 2/8 | ENST00000358741.4 | NP_851820.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NLGN3 | ENST00000358741.4 | c.70C>T | p.Leu24Phe | missense_variant | 2/8 | 5 | NM_181303.2 | ENSP00000351591.4 | ||
NLGN3 | ENST00000685718.1 | n.70C>T | non_coding_transcript_exon_variant | 2/8 | ENSP00000510514.1 |
Frequencies
GnomAD3 genomes AF: 0.0000179 AC: 2AN: 111934Hom.: 0 Cov.: 22 AF XY: 0.0000293 AC XY: 1AN XY: 34080
GnomAD3 exomes AF: 0.00000565 AC: 1AN: 176976Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 62560
GnomAD4 exome Cov.: 31
GnomAD4 genome AF: 0.0000179 AC: 2AN: 111987Hom.: 0 Cov.: 22 AF XY: 0.0000293 AC XY: 1AN XY: 34143
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 30, 2024 | The c.70C>T (p.L24F) alteration is located in exon 2 (coding exon 1) of the NLGN3 gene. This alteration results from a C to T substitution at nucleotide position 70, causing the leucine (L) at amino acid position 24 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at